PCVX
Price
$51.95
Change
-$0.16 (-0.31%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
7.5B
50 days until earnings call
Intraday BUY SELL Signals
TRDA
Price
$7.24
Change
+$0.17 (+2.40%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
281.06M
50 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PCVX vs TRDA

PCVX vs TRDA Comparison Chart in %
View a ticker or compare two or three
VS
PCVX vs. TRDA commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCVX is a Buy and TRDA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (PCVX: $52.11 vs. TRDA: $7.07)
Brand notoriety: PCVX and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PCVX: 98% vs. TRDA: 62%
Market capitalization -- PCVX: $7.5B vs. TRDA: $274.46M
PCVX [@Biotechnology] is valued at $7.5B. TRDA’s [@Biotechnology] market capitalization is $274.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PCVX’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • PCVX’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, PCVX is a better buy in the long-term than TRDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PCVX’s TA Score shows that 4 TA indicator(s) are bullish while TRDA’s TA Score has 5 bullish TA indicator(s).

  • PCVX’s TA Score: 4 bullish, 4 bearish.
  • TRDA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, TRDA is a better buy in the short-term than PCVX.

Price Growth

PCVX (@Biotechnology) experienced а +5.15% price change this week, while TRDA (@Biotechnology) price change was +7.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

PCVX is expected to report earnings on Aug 12, 2026.

TRDA is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($7.5B) has a higher market cap than TRDA($281M). PCVX YTD gains are higher at: 12.939 vs. TRDA (-31.226). TRDA has higher annual earnings (EBITDA): -174.46M vs. PCVX (-1.06B). PCVX has more cash in the bank: 1.74B vs. TRDA (76.4M). TRDA has less debt than PCVX: TRDA (49.8M) vs PCVX (116M). TRDA has higher revenues than PCVX: TRDA (5.74M) vs PCVX (0).
PCVXTRDAPCVX / TRDA
Capitalization7.5B281M2,669%
EBITDA-1.06B-174.46M609%
Gain YTD12.939-31.226-41%
P/E RatioN/A10.26-
Revenue05.74M-
Total Cash1.74B76.4M2,274%
Total Debt116M49.8M233%
FUNDAMENTALS RATINGS
PCVX: Fundamental Ratings
PCVX
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
77
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
49
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PCVXTRDA
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 6 days ago
86%
Declines
ODDS (%)
Bearish Trend 16 days ago
72%
Bearish Trend 16 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
PCVX
Daily Signal:
Gain/Loss:
TRDA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBMRX29.680.08
+0.27%
Neuberger M/C Intrinsic Val R6
WOOPX18.46N/A
N/A
JPMorgan SMID Cap Equity I
KTCAX55.39N/A
N/A
DWS Science and Technology A
FTZIX75.69N/A
N/A
FullerThaler Behavrl Uncnstd Eq
JMGPX50.89N/A
N/A
JPMorgan Mid Cap Growth R3

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with VIR. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
+1.30%
VIR - PCVX
53%
Loosely correlated
+4.48%
DNLI - PCVX
49%
Loosely correlated
+3.17%
BCYC - PCVX
49%
Loosely correlated
-0.63%
BCAX - PCVX
46%
Loosely correlated
+5.73%
AVBP - PCVX
45%
Loosely correlated
+3.02%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been closely correlated with ENGN. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRDA jumps, then ENGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
-0.28%
ENGN - TRDA
77%
Closely correlated
-1.45%
INSM - TRDA
50%
Loosely correlated
+2.93%
KRRO - TRDA
42%
Loosely correlated
+6.70%
CELC - TRDA
42%
Loosely correlated
+2.47%
PCVX - TRDA
40%
Loosely correlated
+1.30%
More